A detailed history of American International Group, Inc. transactions in Organon & Co. stock. As of the latest transaction made, American International Group, Inc. holds 13,958 shares of OGN stock, worth $288,930. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,958
Previous 14,102 1.02%
Holding current value
$288,930
Previous $203,000 29.06%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$13.78 - $18.8 $1,984 - $2,707
-144 Reduced 1.02%
13,958 $262,000
Q4 2023

Feb 13, 2024

SELL
$10.95 - $17.32 $586,065 - $927,001
-53,522 Reduced 79.15%
14,102 $203,000
Q3 2023

Nov 13, 2023

SELL
$16.59 - $23.77 $23,989 - $34,371
-1,446 Reduced 2.09%
67,624 $1.17 Million
Q2 2023

Aug 04, 2023

BUY
$19.27 - $24.63 $520 - $665
27 Added 0.04%
69,070 $1.44 Million
Q1 2023

May 12, 2023

BUY
$21.42 - $32.08 $4,091 - $6,127
191 Added 0.28%
69,043 $1.62 Million
Q4 2022

Feb 10, 2023

SELL
$23.31 - $28.61 $9,627 - $11,815
-413 Reduced 0.6%
68,852 $1.92 Million
Q3 2022

Nov 14, 2022

SELL
$23.4 - $34.25 $33,485 - $49,011
-1,431 Reduced 2.02%
69,265 $1.62 Million
Q2 2022

Aug 12, 2022

SELL
$31.66 - $38.9 $62,686 - $77,022
-1,980 Reduced 2.72%
70,696 $2.39 Million
Q1 2022

May 13, 2022

SELL
$30.45 - $39.36 $67,903 - $87,772
-2,230 Reduced 2.98%
72,676 $2.54 Million
Q4 2021

Feb 11, 2022

SELL
$28.67 - $37.13 $44,237 - $57,291
-1,543 Reduced 2.02%
74,906 $2.28 Million
Q3 2021

Nov 12, 2021

SELL
$28.63 - $35.64 $38,707 - $48,185
-1,352 Reduced 1.74%
76,449 $2.51 Million
Q2 2021

Aug 13, 2021

BUY
$28.45 - $38.0 $2.21 Million - $2.96 Million
77,801 New
77,801 $2.35 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $5.26B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.